Role of the CCN protein family in canceropen access
- Authors
- Kim, Hyungjoo; Son, Seogho; Shin, Incheol
- Issue Date
- Oct-2018
- Publisher
- KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
- Keywords
- Cancer; CCN family; Matricellular protein; Signal transduction; Therapeutic target
- Citation
- BMB REPORTS, v.51, no.10, pp.486 - 492
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- BMB REPORTS
- Volume
- 51
- Number
- 10
- Start Page
- 486
- End Page
- 492
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/16027
- DOI
- 10.5483/BMBRep.2018.51.10.192
- ISSN
- 1976-6696
- Abstract
- The CCN protein family is composed of six matricellular proteins, which serve regulatory roles rather than structural roles in the extracellular matrix. First identified as secreted proteins which are induced by oncogenes, the acronym CCN came from the names of the first three members: CYR61, CTGF, and NOV. All six members of the CCN family consist of four cysteine-rich modular domains. CCN proteins are known to regulate cell adhesion, proliferation, differentiation, and apoptosis. In addition, CCN proteins are associated with cardiovascular and skeletal development, injury repair, inflammation, and cancer. They function either through binding to integrin receptors or by regulating the expression and activity of growth factors and cytokines. Given their diverse roles related to the pathology of certain diseases such as fibrosis, arthritis, atherosclerosis, diabetic nephropathy, retinopathy, and cancer, there are many emerging studies targeting CCN protein signaling pathways in attempts to elucidate their potentials as therapeutic targets.
- Files in This Item
-
- Appears in
Collections - 서울 자연과학대학 > 서울 생명과학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/16027)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.